pI: 6.1234 |
Length (AA): 474 |
MW (Da): 52876 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 299 | 1yhv (A) | 249 | 541 | 38.00 | 0 | 1 | 1.18 | -1.17 |
9 | 299 | 1u5q (A) | 17 | 301 | 41.00 | 0 | 1 | 1.17 | -1.27 |
19 | 362 | 2hak (A) | 51 | 364 | 25.00 | 0 | 1 | 0.83 | -0.38 |
10 | 392 | 4rgj (A) | 57 | 462 | 22.00 | 0 | 1 | 0.998117 | 0.13 |
16 | 294 | 4u3y (A) | 20 | 311 | 46.00 | 0 | 1 | 1.15371 | -1.12 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128604)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G69220 | putative serine/threonine kinase |
Brugia malayi | Bm1_32140 | STE20-like kinase MST |
Candida albicans | CaO19.3049 | kinase required for spore wall formation |
Candida albicans | CaO19.10567 | kinase required for spore wall formation |
Caenorhabditis elegans | CELE_F14H12.4 | Protein CST-1, isoform B |
Caenorhabditis elegans | CELE_C24A8.4 | Protein CST-2 |
Cryptosporidium hominis | Chro.70160 | serine/threonine protein kinase; possibly sporulation specific |
Dictyostelium discoideum | DDB_G0274593 | STE20 family protein kinase |
Dictyostelium discoideum | DDB_G0284181 | MST subfamily kinase |
Drosophila melanogaster | Dmel_CG11228 | hippo |
Echinococcus granulosus | EgrG_000067500 | serine:threonine protein kinase 3 |
Entamoeba histolytica | EHI_156670 | serine/threonine-protein kinase 3, putative |
Entamoeba histolytica | EHI_192540 | serine/threonine protein kinase STE20, putative |
Echinococcus multilocularis | EmuJ_000364700 | myosin iiia |
Echinococcus multilocularis | EmuJ_000067500 | serine:threonine protein kinase 3 |
Giardia lamblia | GL50803_15514 | Kinase, STE STE20 |
Homo sapiens | ENSG00000101109 | serine/threonine kinase 4 |
Homo sapiens | ENSG00000104375 | serine/threonine kinase 3 |
Leishmania braziliensis | LbrM.16.0300 | protein kinase, putative |
Leishmania donovani | LdBPK_160310.1 | protein kinase, putative |
Leishmania infantum | LinJ.16.0310 | protein kinase, putative |
Leishmania major | LmjF.16.0300 | protein kinase, putative |
Leishmania mexicana | LmxM.16.0300 | protein kinase, putative |
Loa Loa (eye worm) | LOAG_07747 | STE/STE20/MST protein kinase |
Mus musculus | ENSMUSG00000018209 | serine/threonine kinase 4 |
Mus musculus | ENSMUSG00000022329 | serine/threonine kinase 3 |
Oryza sativa | 4334150 | Os03g0755000 |
Plasmodium knowlesi | PKNH_0418000 | protein kinase, putative |
Schmidtea mediterranea | mk4.011996.00 | Serine/threonine-protein kinase flr-4 |
Schmidtea mediterranea | mk4.010105.01 | |
Schmidtea mediterranea | mk4.009495.01 | |
Schmidtea mediterranea | mk4.000035.12 | |
Trypanosoma brucei gambiense | Tbg972.8.5730 | protein kinase, putative |
Trypanosoma brucei | Tb927.8.5730 | STE20-like serine/threonine-protein kinase 1, putative |
Trypanosoma congolense | TcIL3000_8_5520 | protein kinase, putative |
Trypanosoma cruzi | TcCLB.506743.160 | STE/STE20 serine/threonine-protein kinase, putative |
Trypanosoma cruzi | TcCLB.503473.10 | STE/STE20 serine/threonine-protein kinase, putative |
Trichomonas vaginalis | TVAG_268810 | STE family protein kinase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.5730 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.5730 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.5730 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.8.5730 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.7
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | serine/threonine kinase 4 | Compounds | References |
Homo sapiens | serine/threonine kinase 3 | Compounds | References |
Mus musculus | serine/threonine kinase 3 | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Zea mays | Casein kinase II alpha | 332 aa | 25.3% | 308 aa | Compounds | References |
Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 32.9% | 161 aa | Compounds | References |
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 28.9% | 253 aa | Compounds | References |